High risk stage II colon cancer (CC) patients who will benefit from adjuvant treatment remains a clinical concern; however, no ideal model has been applied to clearly identify which suitable stage II CC patients should receive adjuvant chemotherapy. A previous study has provided an ideal and quantifiable model to identify suitable high risk stage II CC patients who should receive adjuvant chemotherapy after undergoing non-emergent surgery. This study is of importance; however, more factors should be taken into considerations to modify the prognostic model, which still requires further validation. To investigate whether cytokine-induced killer cells (CIK)/ dendritic cell (DC)-CIK therapy is able to improve the therapeutic efficacy of chemotherapy in gastric cancer. We conducted a systematic review in latest published papers from the sources of several databases. The effects (95% CIs) of chemotherapy were compared with those of chemotherapy in combination with CIK/DC-CIK immunotherapy.
Schistosoma Mansoni represents an important tropical disease that can cause schistosomiasis mostly in Africa and Middle East with high mortality rates. Moreover, no vaccine against it exists. This study predicts an effective epitope-based vaccine against Fructose 1,6 Bisphosphate Aldolase (FBA) enzyme of Schistosoma Mansoni using immunoinformatics approaches. FBA is important for production of energy required for different schistosome activities and survival. The sequences were retrieved from NCBI and several prediction tests were conducted to analyze possible epitopes for B-cell, T-cell MHC class I and II. Tertiary structure of the most promising epitopes was obtained. Two epitopes showed high binding affinity for B-cells, while four epitopes showed high binding affinity for MHCI and MHCII. The results were promising to formulate a vaccine with more than 99.5% population coverage. We hope that these promising epitopes serves as a preventive measure for the disease in the future and recommend invivo and invitro studies.
Intravesical immunotherapy with BCG for the treatment of nonmuscle invasive bladder cancer is used routinely, urological complications can be variable from self-limited to some that can put the patient's life at risk, in addition, the complications can develop immediately after instillation or years after the end of treatment. India Bacillus Calmette Guerin (BCG) was approved by the Food and Drug Administration (FDA) in 1990, it´s a live attenuated vaccine derived from Mycobacterium Bovis. Is the standard treatment for intravesical immunotherapy for nonmuscle invasive bladder cancer. Its use is very common in urologists
Humans come into contact with potentially dangerous diseasecausing species or pathogens, such as bacteria or viruses, every day they live. Despite this, the majority of us are still able to act normally and live our lives without being sick all of the time. That's because a multilayered immune system is needed to keep the human body working smoothly. When a pathogen infiltrates a cell, cytoplasmic receptors detect the invasion and stimulate the immune response to prevent the pathogen from replicating. Another innate defence mechanism is the mobilisation of Natural Killer (NK) cells, which can identify virus-infected cells and destroy them right away, preventing rapid viral spread. Adaptive or acquired immunity is a supplemental type of immunity found in vertebrates. Unlike innate immunity, this form of defence has a memory. When an infection is replicated, the adaptive arm of the immune system allows for a faster and more systematic immune response. For any novel infection, the lack of immediate cooperation between innate and adaptive immunity for infection suppression is a huge advantage.
The uncontrolled proliferation of aberrant cells in the body is known as cancer. May affect any body tissue and take many distinct forms in different parts of the body. Damaged cells proliferate, divide, and spread abnormally instead of self-destructing as they should resulting in cancer. When a cell is severely injured and unable to heal itself, it goes through a process known as apoptosis, or programmed cell death. Cancer is that disease that can grow in any part of the body. One of the most common cancers in women is breast cancer and for men is prostate cancer. Both men and women are affected by lung cancer and colorectal cancer in large numbers. The growing body of knowledge about cancer's development and progression can be exploited to generate more precise diagnostics and/or less hazardous cancer treatments.With the artificial information is advancing, cancer treatment is becoming more precise and accurate, likewise, with cutting edge technology, healthcare facilitate can be equipped more effectively to support healthcare provider to work more efficiently, however, new healthcare facility commissioning process should be safety and quality-oriented activities which validate and document the performance of not only facility but system as well, during the process commissioning team will verify to see if the original or defined objective and criteria are met.
The progression in science gives novel and deeper understandings of human beings organisms. The Human Genome Project uncovered about 20,500 human genes. More recently, non-coding RNAs saw the light and gained researchers interest. Among the different subsets of these non-coding RNAs, microRNAs were identified as 18-25 nucleotides long and have been shown to play critical regulatory roles in a wide range of cellular processes. Emerging studies highlighted the importance of miRNAs in health and in disease. Ten years ago, the role of miRNAs in cutaneous system has been established from skin formation in early life to skin homeostasis maintenance. In addition, a deregulated miRNAs profile was shown to cause major skin disorders. Herein, in this review, a global discussion and findings of the different aspects of miRNAs biology will be covered with a focus on the role of miRNAs in skin biology.
The emergence of newer SARS-CoV-2 variants recently reported in the UK, South Africa, and Brazil is a matter of great concern. The mutations mainly in the spike protein are the culprit behind the sudden rise in the infectivity and transmission of these variants. The scientific efforts provided us with few effective vaccines like Pfizer and Moderna, however the same needs to be re-investigated in the SARS-CoV-2 variants infected patients. This brief review, focuses on the emergence, how the variants originated and are geographically distributed around the world, which will make the researcher aware of the current pandemic situation
Hypersensitivity Autoimmunity is the system of immune responses of an organism which attacks its own healthy cells, tissues and other normal components Immune system which mistakenly attacks your own body is termed as \"autoimmune diseases\" Early symptoms of autoimmunity are such as achy muscles, hair loss, swelling, numbness in the hands and feet, skin rashes and fatigue Some immune diseases can always have their own unique symptoms Here, Robert discusses how to improve your immune system and the treatment for auto immune disease
Hypersensitivity is also called as hypersensitivity reaction or intolerance. When there is an obnoxious responses produced by the interaction of the normal immune system with an allergen (antigen), are referred as Hypersensitivity. These reactions can be damaging, uncomfortable or might occasionally cause fatal. The vulnerability of a person to these reactions can have a genetic link. Overreaction to these self-antigens is normally due to a failure in central tolerance, and this resulted in failure so we can see genetically-inheritable features. In order to cause a hypersensitivity reaction, it needs two separate interactions between the immune system and the antigen
Saline-based therapies had been considered as promising options for COVID-19 due to the augment of innate responses. SARS-CoV-2 may be present in lower respiratory tracts (LRT) during early stage of the infection, therefore inhaled therapies are ideal to supply saline for the entire airway tract. This is possible with ultrasonic humidifiers that can aerosolize any mineral content in the input water, continuously producing micron- and submicron-sized aerosols that may reach both the upper respiratory tract and LRT. The virucidal action of saline has been demonstrated with not only hypertonic but also with isotonic and hypotonic saline. Therefore, we recommend investigation of the antiviral activity of hypotonic saline for long-term administration as starting points for future experimental designs. Given the persistence of the antiviral response post-treatment, the prevention of COVID-19 via daily administration of nebulized chloride therapy should be examined. In brief, ultrasonic humidifiers could be adapted to produce an inexpensive, simple, and promising therapy for COVID-19.
Purpose: To report a case of a patient with a Full-Thickness Macular Hole (FTMH) treated with a Pars-Plana Vitrectomy (PPV) and the positioning of a human Amniotic Membrane (hAM) plug. Methods: Patient was surgically treated with PPV, hAM plug implantation and SF6 (sulfur hexafluoride) as endotamponade. A complete ophthalmic examination and an Optical Coherence Tomography (OCT) were performed at every visit. Results: After surgery, the edges of hAM were elevated, folded and not perfectly outspread under the surrounding retinal layers, which were thickened and elevated, due to the presence of a persistent intraretinal oedema. A new surgery with reinjection of 20% SF6 was performed, but despite the closure of MH, neurosensory retina migration over the hAM plug was incomplete and macular edema persisted. Conclusion: hAM transplant is a valuable option for MH surgery. Plug dimension should be calibrated on MH diameter, and correctly spread under the edges of the hole itself. In cases of persistent macular hole, a new surgery with reinjection of 20% SF6 can be used to promote macular hole closure. Preoperative macular edema should be considered as a negative prognostic factor for MH closure.
A mosaic of various inflammatory diseases associated with the administration of vaccines has been reported in the literature. Optic Neuritis (ON), a primary inflammation of the optic nerve, serves as an prominent piece of it, presenting the features of autoimmune phenomena including Treg/Th17 cell imbalance and the abundance of proinflammatory cytokines. A PubMed search revealed 48 cases of vaccination-related ON, from which 32 were reports as isolated ON, 9 occurred as the first symptom of neuromyelitis optica spectrum diseases (NMOSD) and 6 were inscribed in clinical course of Acute Disseminated Encephalomyelitis (ADEM). In Vaccine Adverse Effects Reporting System (VAERS) 537 reports of ON were identified, the vast majority of them was isolated (n=284), followed by ON preceding multiple sclerosis (n=99), ADEM (n=30) and NMOSD (n=20). Influenza vaccine was the leading cause of isolated ON, hepatitis B vaccine (HBV) was mostly associated with diseases entailing further demyelination, such as multiple sclerosis. Moreover, the time interval between vaccine delivery and symptoms of ON occurrences was shorter in cases of isolated-ON in comparison to ON-MS and ON-NMOSD. This time gap was also considerably longer after vaccines enriched with aluminum adjuvant. This article presents the thorough analysis of vaccination related ON cases and focuses on the possible pathomechanism of this autoimmune interplay, including the impact of adjuvants and the mechanism of molecular mimicry.
In wildlife, the natural reservoir host for most animal viruses, overt clinical infections are generally absent. In this paper it is hypothesized that for hundreds of millions of years viruses co-evolved with arthropods, fishes, amphibians, reptiles, birds, and mammals, in a friendly manner, by minimizing virus replication costs and host damage. This virus-host mutualism hypothesis may be viewed as diametrically opposite to the virulence transmission hypothesis. Building on previous work, the transmission ecologies of 36 of the world main livestock viruses are examined in more detail. Viruses and organ systems are aligned on ecological grounds, in an outer to inner-body fashion. The virus-host interplay changes from acute to persistent infection to ever more virus-host intimacy. From outer to inner-body virus-host mutualism is on the increase. Virus-host antagonism increases from inner to outer-body. Also explored is the role of the host domain in mutualism-antagonism evolution. For this, the virus evolution trajectory upon a host shift from wildlife to humans or livestock is examined. Again, epithelial viruses are contrasted to non- epithelial, fully internalized viruses. It is found that a-clinical enteric viruses of wild birds and bats, in humans and livestock evolve as respiratory or also enteric pathogens. Viral virulence is most prominent among respiratory and enteric poultry and pig viruses. Regarding the internalized viruses, it is found that upon a transfer from wildlife to humans or livestock as host, the virus evolves to return to the sylvatic trait profile, very gradually so. Collectively, the results of this study corroborate the notion that in natural ecosystems friendly virus-host relationships tend to be selected for. Evolution of viral virulence and other forms of pathogenic fitness, including immune-suppression, primarily occur in animal smass rearing and so are anthropogenic in nature. The crowd agents circulating in humans as host take an intermediary position.
A deadly pneumonia outbreak of unknown etiology emerged in Wuhan, China in December, 2019, which soon gripped whole of the world and was subsequently declared as ‘first ever pandemic caused by any coronavirus till date’ by World Health Organization. The agent responsible for this apocalpse was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the infection was officially named as coronavirus disease (COVID-19).
Silicone has been widely used over the last two decades, mainly for aesthetic purposes. Growing data show that local free/liquid silicone injections, used as body filler, are possibly related to the onset of adverse effects, with autoimmune and inflammatory features. Several reactions have been described, some of which can be classified as ASIA-Autoimmune/Inflammatory Syndrome Induced by Adjuvants. Clinical presentations range from local inflammatory reactions to full-blown systemic autoimmune diseases. These cases share the similar chronological, clinical and histopathological features, as well as treatment rationale. The link between silicone breast implants and autoimmune disorders are still under debate, but local liquid silicone injections adverse effects are sporadically reported. The aim of this review is to identify common features of autoimmune and inflammatory adverse effects of local liquid silicone injections.
I am pleased to inform you that, Immunome Research has released its 15th volume in the year of 2019. As like before years IMR released issues trimonthly i.e, in the months of April, August, and December without any fail in addition, 3 conference proceedings were published Immunome Research has benefits like fast-track peer-review process has advantage with highly eminent. Journal impact factor for IMR is 1.65*. And also IMR is having NLM Id: 101245791 and ISSN: 1745-7580.
N 6 -methyladenosine (m 6 A) plays critical roles in a broad set of biological processes.Knowledge about the precise location of m 6 A site in the transcriptome is vital for deciphering its biological functions.Although experimental techniques have made substantial contributions to identify m 6 A methylations, they are still labor intensive, costly and time consuming.As good complements to experimental methods, in the past few years, a series of computational approaches have been proposed to identify m 6 A sites in Saccharomyces cerevisiae.In order to facilitate researchers to select appropriate methods for identifying m 6 A sites, it is necessary to give a comprehensive review and comparison on existing computational methods.In this review, we summarized the current progresses in computational prediction of m 6 A sites and also assessed the performance of computational methods for identifying m 6 A sites on an independent dataset.Finally, challenges and future directions of computationally identifying m 6 A sites were presented as well.Taken together, we anticipate that this review will provide an important guide for future computational analysis of m 6 A and other RNA modifications.
The strength of Corona virus disease 2019 (COVID-19) is the fact that it is a novel virus to humans. Being a neoteric virus yields a significant advantage as the person infected possess no immunity to the pathogen. The most significant protection against a new viral infection is the ancient innate immune system. When the virus invades our cells, receptors in the cytoplasm recognize the foreign intruder and induce innate immune responses to block replication of the virus. A robust response is critical as it takes three to five days to generate the beginnings of an adaptive immune response. The front line innate immune response is often powerful enough to eliminate the virus before the development of more severe late-phase infection, which relies on acquired immunity for resolution. A recent scientific discovery demonstrates a natural, safe, and accessible self-administered procedure that enhances our innate immunity. Non-myeloid epithelial cells are capable of producing the viricidal substance hypochlorous acid (HOCL). The amount of HOCL generated is dependent on the concentration of intracellular chloride that is available. In vitro, saline exposure of epithelial cells infected with coronavirus significantly reduced viral replication. In vivo, hypertonic saline nasal irrigation and gargle (HSNIG) in patients who had upper respiratory infections (URI) caused by coronavirus significantly reduced the duration and severity of the URI compared to similarly infected patients treated with the standard of care. HSNIG can suppress viral replication of COVID-19 mitigating the spread during the asymptomatic phase and reducing the risk of an asymptomatic or symptomatic case progressing to a severe infection.
In 1952, the first immunoglobulin products, made from human plasma, were used to combat infectious diseases such as primary immunodeficiencies during World War II. In addition, during the last 50 years, further research has been conducted to prove whether or not immunoglobulin therapy can truly be effective against primary immunodeficiencies such as X-linked agammaglobulinemia or Common Variable Immunodeficiency Disorder through both intravenous and subcutaneous administration. Intravenous administration has been effective in increasing overall Ig serum concentration in the blood for patients with primary or secondary disorders. However, as more research was conducted, scientists had concluded that the overall cost, maintenance, and at times, lack of efficiency, makes intravenous administration a burden. Thus, scientists have looked for an alternative through subcutaneous administration. For patients with primary immunodeficiencies, subcutaneous has been proven effective in increasing immunoglobulin concentration, even more than intravenous has. The benefit of subcutaneous administration at-home, the low cost, and the heightened efficacy make subcutaneous administration far better than intravenous for primary immunodeficiency patients. However for secondary immunodeficiency patients, the efficacy of subcutaneous administration has not been fully proven and the research is scarce and unreliable. Our literary review explores the advent of immunoglobulin therapy and its past research on both intravenous and subcutaneous administration for primary and secondary immunodeficiency disorders. We sought out to find potential experimental values researchers can conduct experiments to enhance the research on subcutaneous administration for secondary immunodeficiency patients.
Antimicrobials 2020 invites research scholars & young scientists, to submit the nominations for Young Scientist Awards: Antimicrobials 2020. This Antimicrobials 2020 Young Scientist Awards will be announced at the upcoming “8th World Congress on Antibiotics, Antimicrobials & Antibiotic Resistance” at Singapore this April 27-28, 2020.
